Stratus® Medical announces FDA 510k clearance for the Vesta® RF Cannula to expand product portfolio and the first Vesta patient treatments in the United States

SALT LAKE CITY, July 27, 2020 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced today FDA clearance for the Vesta RF Cannula for use in radiofrequency (RF) heat lesion procedures for the relief of pain and first Vesta patient treatments in the United States.  

Vesta was developed to provide our customers and their patients a high quality and cost-effective RF cannula to treat pain in clinical scenarios where our Nimbus® RF Multitined Expandable Electrode, that provides a large volume lesion for the treatment of pain, is not indicated.  

Vesta has been CE marked since 2018 and been used successfully in thousands of procedures in Australia and Brazil.  The recent FDA clearance allows Stratus Medical to market the Vesta RF Cannula in the United States and continue our expansion into new markets across the world. 

Bret Boudousquie, Stratus Medical CEO shared, “Vesta allows us to deliver a more complete product offering and better serve our customers in alignment with their financial needs. Our focus is the rapidly expanding global radiofrequency (RF) for pain market, and the Stratus Medical mission is to reduce pain and suffering and improve quality of life for chronic pain patients by advancing RF technology for the treatment of pain.  We will continue to invest in product development in the RF space and deliver new product launches with the goal to improve patient outcomes.”   

Dr. Alan Swearingen, with Space City Pain in Houston Texas, was the first interventional pain medicine physician to use Vesta in a clinical case and commented, “My colleagues Dr. Eduardo Garcia and Dr. Jeffery Cannella have been using Nimbus for some time and introduced me to the technology and Stratus Medical. Today we had a patient that I thought would benefit from Vesta and both my patient and I are very pleased with the outcome. With its high quality, great value, and proven effectiveness, I foresee many more of my patients benefiting from Vesta in the future.”

About Stratus Medical – Stratus Medical is a medical device company focused on reducing pain and suffering and improving the quality of life for chronic pain patients through innovation.  Stratus Medical is headquartered in Salt Lake City, UT where we manufacture the Nimbus® RF Multitined Expandable Electrode that was developed to address the need for an easy to use and cost-effective RF device that provides a large volume lesion to treat pain.   

Media Contact
Cody Jorgensen
Marketing Communications 
Stratus Medical 
385-707-3029
cody@stratusmedical.com
https://stratusmedical.com

SOURCE Stratus Medical

Related Links

stratusmedical.com

Background:

Radiofrequency neurotomy (RFN) can be an effective treatment for patients with chronic neck pain and cervicogenic headaches resistant to conservative care. However, the degree and duration of pain relief after RFN is dependent upon the thoroughness of target nerve coagulation.

Case Report:

This is a case of a 37-year-old patient with debilitating neck pain and headaches following a motor vehicle accident. Successful local anesthetic block of the third occipital nerve (TON) confirmed pain of C2-C3 facet joint origin. An initial RFN treatment of the TON, using standard 18G electrodes in bipolar mode, resulted in complete symptom amelioration for 8 months. Repeat RFN, using the same electrode configuration, was unsuccessful in alleviating the severe neck pain and headaches, and produced no demonstrable sensory loss in the distribution of the TON. RFN was then performed using the NIMBUS® electrosurgical RF multitined expandable electrode, which provides a larger zone of coagulation in volume than standard RFN electrodes even when used in bipolar configuration.

Conclusion:

The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.

.elementor-element-6a4dca25 .elementor-heading-title { color: #2A90C3 !important; font-weight: 400 !important; text-align: center !important; font-size: 31px !important; } .elementor-element-7f491b95 { text-align: center !important; } .elementor-element-7f491b95 .elementor-icon-list-text, .elementor-element-7f491b95 time { color: #54595F !important; } .elementor-element-7f491b95 a { color: #54595F !important; } .elementor-element-35001cdd > .e-con-inner { padding-left: 8% !important; padding-right: 8% !important; }